While the specific roles of the kinetochore’s molecular components and their interactions remain largely undefined, increasing evidence indicates that ZWINT is often overexpressed in various human cancers, correlating with unfavorable clinical outcomes and early recurrence [5–7]. The gene discussed is ZWINT; the disease is cancer.